Skip to main content
Equibles
HALO logo

HALO · Halozyme Therapeutics, Inc. · Held by Funds

Track HALO — free

Use HALO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HALO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$100.27 -0.40 (-0.40%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$11.43B
Shares
114.01M
Volume · Nov 13 2.28M Avg daily vol (3M) 2.24M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of HALO by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 25.87% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 3.43% 3,907,105
Index ETFs 22.44% 25,583,071
Active ETFs 1.44% 1,645,407
Active funds 14.65% 16,698,762
Unclassified 1.43% 1,629,118
All registered funds 43.39% 49,463,463
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding HALO

572 fund positions
Fund Balance Value % of Fund Open
iShares Core S&P Mid-Cap ETF 4,059,222 $317,715,306 0.26%
VANGUARD TOTAL STOCK MARKET INDEX FUND 3,762,787 $294,513,338 0.01%
VANGUARD SMALL-CAP INDEX FUND 2,721,119 $212,981,984 0.11%
Invesco Discovery Fund 1,382,875 $147,262,359 1.99%
VANGUARD SMALL-CAP GROWTH INDEX FUND 1,566,912 $122,642,202 0.26%
Disciplined Value Mid Cap Fund 1,430,565 $111,970,323 0.48%
State Street(R) SPDR(R) S&P(R) Biotech ETF 1,412,358 $110,545,261 1.03%
VANGUARD EXTENDED MARKET INDEX FUND 1,359,907 $106,439,921 0.11%
First Trust NYSE Arca Biotechnology Index Fund 1,119,086 $87,590,861 3.11%
FULLERTHALER BEHAVIORAL SMALL-CAP GROWTH 968,755 $75,824,454 1.23%
State Street SPDR S&P MidCap 400SM ETF Trust 912,613 $71,430,220 0.25%
VANGUARD EXPLORER FUND 832,286 $68,696,886 0.31%
iShares Biotechnology ETF 831,875 $65,110,856 0.72%
Neuberger Genesis Fund 598,806 $63,766,851 0.88%
Fidelity Extended Market Index Fund 578,372 $61,590,834 0.15%
Schwab U.S. Small-Cap ETF 563,993 $60,059,615 0.27%
Wasatch Core Growth Fund 534,609 $59,020,834 2.57%
iShares S&P Mid-Cap 400 Growth ETF 709,843 $55,559,412 0.49%
Strategic Advisers U.S. Total Stock Fund 521,565 $55,541,457 0.06%
iShares Russell Mid-Cap Growth ETF 693,863 $54,308,657 0.25%
Nomura Small Cap Core Fund 495,059 $52,718,833 1.01%
Putnam Small Cap Growth Fund 617,928 $48,365,225 1.42%
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF 600,378 $46,991,586 0.26%
U.S. SMALL CAP PORTFOLIO 496,955 $41,018,666 0.21%
Federated Hermes MDT Mid Cap Growth Fund 494,277 $40,797,624 0.62%
VANGUARD HEALTH CARE INDEX FUND 361,770 $38,524,887 0.17%
iShares Russell Mid-Cap ETF 482,340 $37,752,752 0.07%
Fidelity Mid Cap Index Fund 445,039 $36,733,519 0.07%
LargeCap Growth Fund I 442,936 $36,559,937 0.64%
iShares Russell 1000 Growth ETF 448,551 $35,108,087 0.03%
Schwab U.S. Mid-Cap ETF 328,103 $34,939,688 0.24%
Bridge Builder Small/Mid Cap Growth Fund 441,328 $34,542,743 0.31%
Dimensional U.S. Small Cap ETF 325,861 $26,896,567 0.18%
BlackRock Health Sciences Opportunities Portfolio 246,253 $26,223,482 0.41%
Janus Henderson Venture Fund 332,552 $26,028,845 0.72%
Nationwide Large Cap Equity Portfolio 308,480 $25,461,939 1.00%
Fidelity Total Market Index Fund 226,084 $24,075,685 0.02%
AB DISCOVERY GROWTH FUND, INC. 295,758 $23,148,979 0.80%
Oberweis Small-Cap Opportunities Fund 274,800 $21,508,596 0.76%
Congress Small Cap Growth Fund 258,000 $21,295,320 1.06%
VANGUARD S&P MID-CAP 400 INDEX FUND 195,129 $20,779,287 0.35%
VANGUARD RUSSELL 1000 GROWTH INDEX FUND 191,398 $20,381,973 0.04%
Fidelity Series Total Market Index Fund 184,970 $19,697,455 0.02%
William Blair Small-Mid Cap Growth Fund 243,000 $19,019,610 1.45%
Goldman Sachs Small/Mid Cap Growth Fund 176,645 $18,810,926 1.60%
First Trust Health Care AlphaDEX Fund 226,384 $18,685,735 1.78%
Nomura Healthcare Fund 220,000 $17,219,400 2.30%
William Blair Small Cap Growth Fund 217,890 $17,054,250 1.39%
Boston Trust Walden Small Cap Fund 204,417 $15,999,719 1.52%
Dimensional U.S. Core Equity 2 ETF 192,370 $15,878,220 0.03%
Showing 1–50 of 572 positions
Key facts CIK 1159036 CUSIP 40637H109 13F (30d) 619 filings 569 filers Visit website Investor relations